longevitywatch

Can Chinese herbal medicines lower inflammation markers in your blood?

Yes · Moderate evidence

Studies show that Chinese herbal medicines produce a measurable reduction in blood inflammation markers, most convincingly demonstrated in COVID-19 and sepsis in a hospital setting. Outside those contexts, the available evidence is still limited.

Chinese herbal medicines can lower inflammation markers in the blood, but how strong that effect is, and how certain we can be about it, varies by herb and condition. The clearest evidence comes from research in COVID-19. In more than 10,000 patients, Chinese herbal medicine given on top of standard care lowered the blood marker CRP (a widely used measure of inflammation) by an average of almost 3 mg/L. A smaller analysis confirmed a similar drop of almost 12 mg/L in COVID-19 patients.

In critically ill patients with blood poisoning (sepsis), studies show even larger reductions. The herbal preparation Xuebijing injection lowered CRP by an average of 24 mg/L across 49 studies involving nearly 4,000 patients, alongside improvements in other inflammation markers and lower death rates. The quality of the individual studies varied considerably, and the authors themselves call for larger, better-designed studies. A small study (70 patients) using a different herbal mixture (Dachaihu) in sepsis found improved inflammation and organ function values, but no difference in survival.

In people with COPD, researchers found indications that the herbal mixture Yupingfeng improves inflammation markers. The authors themselves rated the certainty of this particular finding as low. The evidence for lung function was stronger.

The Huanglian Jiedu decoction has been shown in laboratory and animal studies to suppress several substances that promote inflammation. But evidence in people is thin: the available studies are small, not blinded, and almost always combine the formula with other treatments. Whether this also works in people therefore remains uncertain.

If you have a chronic condition and are considering Chinese herbal medicines, discuss this with your doctor. Preparations such as Xuebijing are given intravenously in a hospital setting and are not available as supplements. Safety data for the formulas studied have been reported only to a limited extent, though serious side effects were rarely observed in the individual studies.

The evidence
7 studies · 4 meta-analyses · 3 randomised trials · ≈ 14,819 participants

This answer draws on many studies combined as well as individual studies. The strongest evidence (more than 10,000 patients, COVID-19) is the most reliable, but even there the size of the effect is modest. For sepsis, the pooled evidence covers larger absolute numbers, but the authors themselves argue for better studies. For COPD, the researchers rated the certainty of the inflammation findings as low. For Huanglian Jiedu, the authors stated in their own words that the evidence in people is of "very low certainty", because most studies were small, not blinded, and did not test the classic formula on its own.

Last checked: November 2026 · how this was judged
Related answers

Does turmeric help against inflammation?

Does quercetin work against ageing and inflammation?

Does eating less help your cells clean themselves more effectively?

Do statins lower your CoQ10 levels in your body?

Does paracetamol help with muscle pain?

Related research
18 Nov
Vasodilation and vibration improve brain fluid drainage in people
16 Nov
Brain map of basal ganglia aids Parkinson’s therapy in mice
15 Nov
Diet and prescription drugs appear to slow biological aging; supplements do not
Don't see your question?
Ask it and we'll look it up for you.
Ask a question →
Newsletter

Stay in the loop

Every Thursday, the most important longevity research in your inbox, focused on what you follow.